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Abstract
The aim of the study was to characterise CCR7+ and CCR7-
memory T cells infiltrating the inflamed joints of patients with
juvenile idiopathic arthritis (JIA) and to investigate the functional
and anatomical heterogeneity of these cell subsets in relation to
the expression of the inflammatory chemokine receptors
CXCR3 and CCR5. Memory T cells freshly isolated from the
peripheral blood and synovial fluid (SF) of 25 patients with JIA
were tested for the expression of CCR7, CCR5, CXCR3 and
interferon-γ by flow cytometry. The chemotactic activity of CD4
SF memory T cells from eight patients with JIA to inflammatory
(CXCL11 and CCL3) and homeostatic (CCL19, CCL21)
chemokines was also evaluated. Paired serum and SF samples
from 28 patients with JIA were tested for CCL21
concentrations. CCR7, CXCR3, CCR5 and CCL21 expression
in synovial tissue from six patients with JIA was investigated by
immunohistochemistry. Enrichment of CD4+, CCR7- memory T
cells was demonstrated in SF in comparison with paired blood
from patients with JIA. SF CD4+CCR7- memory T cells were
enriched for CCR5+  and interferon-γ+  cells, whereas
CD4+CCR7+ memory T cells showed higher coexpression of
CXCR3. Expression of CCL21 was detected in both SF and
synovial membranes. SF CD4+  memory T cells displayed
significant migration to both inflammatory and homeostatic
chemokines. CCR7+ T cells were detected in the synovial tissue
in either diffuse perivascular lymphocytic infiltrates or organised
lymphoid aggregates. In synovial tissue, a large fraction of
CCR7+  cells co-localised with CXCR3, especially inside
lymphoid aggregates, whereas CCR5+ cells were enriched in
the sublining of the superficial subintima. In conclusion, CCR7
may have a role in the synovial recruitment of memory T cells in
JIA, irrespective of the pattern of lymphoid organisation.
Moreover, discrete patterns of chemokine receptor expression
are detected in the synovial tissue.
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Introduction
Migration and accumulation of memory T cells in the syn-
ovium is a critical step in the pathogenesis of chronic
arthritides [1-3]. Chemokines are a large family of small
secreted proteins (8–15 kDa) that control lymphocyte traf-
ficking in physiological and pathological processes. The
evaluation of type and distribution of chemokines and their
ANOVA = analysis of variance; APAAP = alkaline phosphatase–anti-alkaline phosphatase; eOJIA = extended oligoarticular JIA; FITC = fluorescein 
isothiocyanate; GC = germinal centre; IFN = interferon; JIA = juvenile idiopathic arthritis; mAb = monoclonal antibody; MNC = mononuclear cells; 
PB = peripheral blood; PBS = phosphate-buffered saline; pOJIA = persistent oligoarticular JIA; RA = rheumatoid arthritis; RF = rheumatoid factor; 
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receptors in the synovium is therefore crucial to an under-
standing of the mechanisms of synovial T cell recruitment.
From a functional point of view, chemokines can be broadly
classified into two groups: inflammatory and homeostatic
[4]. The inflammatory chemokines are induced by proin-
flammatory stimuli and control the migration of leukocytes
to the site of inflammation. CCR5 and CXCR3 are classical
examples of receptors for inflammatory chemokines [5].
The homeostatic chemokines regulate the basal traffic of
lymphocytes and other leukocytes through peripheral lym-
phoid tissues. CCR7 is an example of a receptor for home-
ostatic chemokines. CCR7 and its ligands (CCL19 and
CCL21) have also been shown to have a pivotal role in the
development and maintenance of secondary lymphoid
organ microarchitecture [4,5]. Recently, the CCR7 chem-
okine receptor has been identified as an important marker
of memory T cell differentiation. It has been proposed that
CCR7+ memory T cells represent a pool of 'central' memory
T cells homing to lymph nodes, where they undergo further
differentiation into CCR7- memory T cells, which migrate to
the peripheral tissues to perform their effector functions
[6].
However, this model has been disputed by other investiga-
tors [7,8] and CCR7+ naive and memory T lymphocytes
have been detected in both normal and inflamed human tis-
sues [9]. Previous studies have shown that Th1-polarised
[10,11], CCR5+ and CXCR3+ lymphocytes are enriched in
synovial inflammatory infiltrates and in synovial fluid (SF)
lymphocytes from patients with adult rheumatoid arthritis
(RA) [12,13] and juvenile idiopathic arthritis (JIA) [14-16].
CCR5 and CXCR3 ligands, namely RANTES (or CCL5)
and macrophage inhibitory protein-1α (MIP-1α, or CCL3),
and interferon-inducible protein-10 (IP-10, or CXCL10)
and ITA-C (CXCL11), respectively, have also been
detected in rheumatoid synovium [17].
Limited information is available on CCR7 expression in syn-
ovial lymphocytes from patients with chronic arthritis. Naive
CD45RA+ T cells with a CCR7 phenotype have been found
to infiltrate the synovial tissue in patients with RA [16]. The
CCR7 ligands CCL19 and CCL21 have been detected in
endothelial cells and in the perivascular infiltrate in RA syn-
ovium, suggesting their potential involvement in lymphoid
neogenesis that occurs in inflamed synovial tissue [18-20].
No information is so far available on the expression of
CCR7 in memory T cells homing to the synovial microenvi-
ronment in relation to expression of the inflammatory chem-
okine receptors CCR5 and CXCR3.
In this study we therefore investigated the expression of
CCR7, CCR5 and CXCR3 on SF and peripheral blood
(PB) memory CD4+ T cells from patients with JIA, chemo-
taxis of the latter cells to the ligands of these receptors, and
the distribution of cells positive for CCR7, CCR5 and
CXCR3 in the inflamed synovium.
Methods
Patients
Immunophenotypic and functional characterisation of
freshly isolated PB and/or SF lymphocytes was performed
in a total of 25 patients with JIA (14 female, 9 male) under-
going therapeutic arthrocentesis. According to ILAR Dur-
ban classification criteria [21], 15 patients had persistent
oligoarticular JIA (pOJIA), 6 had extended oligoarticular JIA
(eOJIA) (which means a total of five or more joints involved
after the first 6 months of disease and therefore a polyartic-
ular course) and 4 had rheumatoid factor (RF)-negative pol-
yarticular JIA. Several clinical (number of active joints,
number of joints with limited range of motion, and physician
global assessment of overall disease activity) and labora-
tory parameters (erythrocyte sedimentation rate, C-reactive
protein, white blood cell and platelet counts, and hemo-
globin serum concentration) of disease activity were
recorded, together with the ongoing treatment, at the time
of the study.
Paired serum and SF samples from 28 additional patients
with JIA (16 with pOJIA, 6 with eOJIA, 4 with RF negative
polyarticular JIA, and 2 with systemic JIA) were tested for
CCL21 concentrations. The clinical characteristics of
patients with JIA and the ongoing treatment at the time of
the study are reported in Tables 1 and 2. For each patient,
SF was collected at the time of intra-articular steroid injec-
tion. Paired serum sample was obtained, with permission,
on the occasion of concomitant routine venipuncture. Both
SF and sera were stored at -80°C immediately after centrif-
ugation. A previous steroid injection into the same joint in
the previous 6 months was considered to be an exclusion
criterion.
Peripheral blood and/or sera from 15 age-matched healthy
subjects attending our clinic for routinary pre-operative
examinations for minor surgical procedures were used as
controls. Synovial tissue from six patients (two with pOJIA,
one with eOJIA and three with RF-negative polyarticular
JIA) was obtained, with permission, at the time of
synoviectomy.
Samples were taken from patients and healthy controls,
and stored after parental permission in accordance with the
informed consent approved by the ethical committee of the
'G. Gaslini' Institute.
Cell preparation and flow cytometry
PB and SF mononuclear cells (MNC) were isolated from
heparinised blood and SF samples by Ficoll–Hypaque
(Sigma, St Louis, MO, USA) density gradientAvailable online http://arthritis-research.com/content/7/2/R256
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centrifugation. Cells were washed, resuspended in com-
plete medium (RPMI 1640 with L-glutamine, penicillin/
streptomycin, nonessential amino acids and 10% fetal
bovine serum; Sigma) and depleted of adherent cells by
adherence to plastic for 1 h at 37°C in 5% CO2. To analyse
the expression of CCR7 on CD4+ memory T cells in SF and
PB MNC, cells were triple-stained with CD45RO-TC
(Caltag, Burlingame, CA, USA), CD4–FITC (BD Bio-
sciences, San Jose, CA, USA) and anti-CCR7–PE (BD
Pharmingen, San Diego, CA, USA) monoclonal antibodies
(mAbs) and analysed by flow cytometry (CellQuest soft-
ware and FACScan; BD Biosciences). CCR7 expression
was evaluated by gating on the CD45RO+CD4+  lym-
phocyte population. CD45RO+ cells were purified from PB
and SF MNC by negative selection with a CD45RA mAb
(Caltag) and goat anti-mouse IgG-coated magnetic beads
(Immunotech, Marseille, France), in accordance with the
manufacturer's instructions. Recovered cells were 95%
enriched for CD45RO+ cells.
CCR5 or CXCR3 expression was investigated by three-
colour staining of freshly isolated SF and PB CD45RO+
cells with fluorescein isothiocyanate (FITC)-conjugated
CD4 (BD Biosciences), anti-CCR7–phycoerythrin (PE)
and anti-CCR5–CyChrome mAbs (BD Pharmingen) or
CD4-TC (where TC stands for Tri-color), anti-CCR7–PE
and anti-CXCR3–FITC (R&D System, Minneapolis, MN,
USA), respectively, gating on the CD4+CCR7+  and
CD4+CCR7- lymphocyte populations.
For interferon (IFN)-γ intracellular staining, freshly purified
SF CD45RO+ cells (106) were incubated for 5 hours in the
presence of phorbol 12-myristate 13-acetate (20 ng/ml;
Sigma), the calcium ionophore A-23187 (250 ng/ml;
Sigma) and brefeldin-A (5 µg/ml; Sigma). Cells were
washed in phosphate-buffered saline (PBS) with 1% fetal
calf serum (staining buffer) and surface stained with CD4–
TC (Caltag) and anti-CCR7–PE (BD Pharmingen) mAbs
for 30 min at 4°C in the dark. Cells were washed in staining
Table 1
Clinical and laboratory features of patients with juvenile idiopathic arthritis at the time of phenotypic and functional studies of 
peripheral blood and synovial fluid lymphocytes
Course No. of patients Age (years) Disease duration 
(years)
No. of joints with active/
limited range of motion
PGI ESR (mm/h) Treatment; n
Polyarticular 10 10.9 (3.3–16.1) 3.2 (0.5–11.2) 6 (1–16)/12.2 (1–29) 8.3 (6–10) 65 (23–131) NSAID, MTX; 7
NSAID, CS, MTX; 2
NSAID alone; 1
Oligoarticular 15 8.5 (3–17.9) 2.4 (0.3–14) 1.3 (1–3)/1.5 (1–3) 6.3 (5–10) 26.5 (7–90) NSAID alone; 11
NSAID, MTX; 2
Nil; 2
Results are means (ranges in parentheses).
CS, corticosteroids; ESR, erythrocyte sedimentation rate; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drugs; PGI, physician global 
index.
Table 2
Clinical and laboratory features of patients with juvenile idiopathic arthritis at the time of determination of CCL21 in sera and 
synovial fluid
Course No. of patients Age (years) Disease duration 
(years)
No. of joints with active/
limited range of motion
PGI ESR (mm/h) Treatment; n
Polyarticular 12 11.5 (4.3–14.3) 3.4 (0.5–1.2) 5.3 (1–13)/18.3 (1–22) 7.8 (5–10) 78 (24–137) NSAID, MTX; 8
NSAID, CS, MTX; 2
NSAID, CS; 1
NSAID alone; 1
Oligoarticular 16 7.5 (2.1–15.9) 2.4 (0.3–14) 1.8 (1–4)/1.9 (1–4) 6.9 (5–10) 31.5 (5–65) NSAID alone; 11
NSAID, MTX; 2
Nil; 3
Results are means (ranges in parentheses). See also 'Patients' in the Methods section.
CS, corticosteroids; ESR, erythrocyte sedimentation rate; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory drugs; PGI, physician global 
index.Arthritis Research & Therapy    Vol 7 No 2    Gattorno et al.
R259
buffer and fixed in 4% paraformaldehyde for 20 min at 4°C
in the dark. Afterwards, the cells were washed twice with
permeabilisation buffer (PBS containing 1% fetal calf
serum and 0.1% saponin [Sigma]) and stained with FITC-
conjugated mAbs against human IFN-γ (Caltag) for 30 min
at 4°C in the dark. Cells were then washed in staining
buffer and analysed by flow cytometry, gating on the
CD4+CCR7+  and CD4+CCR7-  lymphocyte subsets.
Although stimulation with phorbol 12-myristate 13-acetate
and calcium ionophore downregulates the intensity of CD4
and CCR7 expression, the proportion of cells positive for
each marker was similar before and after stimulation.
Isotype matched, PE-, FITC-, TC- and CyChrome-conju-
gated mAbs of irrelevant specificity were tested as negative
controls in all of the above experiments. The results of flow
cytometry experiments were expressed as percentage pos-
itive cells or as mean fluorescence intensity; that is, the
staining intensity of a test mAb minus that of an isotype-
matched, irrelevant control mAb. The threshold for calculat-
ing the percentage positive cells was based on the maxi-
mum staining obtained with irrelevant isotype-matched
mAb, used at the same concentration as the test mAb.
Negative cells were defined such that less than 1% of cells
stained positive with control mAbs. Cells labelled with test
antibody that were brighter than those stained with isotypic
control antibody were defined as positive. Mean fluores-
cence intensities of the isotype control and of test mAbs
were used to evaluate whether the differences between the
peaks of cells were statistically significant with respect to
the control. The Kolmogorov–Smirnov test for the analysis
of histograms was used, in accordance with the CellQuest
software user's guide. Differences between paired PB and
SF MNC of patients with JIA on the one hand, and PB MNC
of healthy controls on the other, were evaluated by the
Kruskal–Wallis analysis of variance (ANOVA) test and the
Wilcoxon rank test.
Chemotactic assays
Migration assays were performed in 24 transwell plates
(pore size 5 µm, polycarbonate membrane; Costar, Cam-
bridge, MA, USA). Freshly purified SF CD45RO+ cells (5 ×
105) were dispensed in the upper chamber in 100 µl, and
600 µl of different chemokines at 100 ng/ml (R&D System)
or medium alone was added to the lower chamber. Migra-
tion was performed in migration medium (RPMI 1640,
0.1% bovine serum albumin; Sigma). Plates were incu-
bated for 2 hours at 37°C. After removal of the transwell
inserts, cells from the lower compartments were collected.
Furthermore, 0.5 ml of 5 mM EDTA was added to the lower
chamber for 15 min at 37°C to detach adherent cells from
the bottom of the wells. Detached cells were pooled with
the previously collected cell suspensions and counted by
staining with trypan blue. To evaluate the percentage of
migrated CD4+ lymphocytes, cell suspensions were dou-
ble-stained with CD4–PE and CD3–FITC mAbs (BD Bio-
sciences) before and after migration and analysed by flow
cytometry. The percentage input was calculated as follows:
100 × (cells migrated to chemokine/total cell number). Dif-
ferences between cells that migrated to a given chemokine
and the same cells that migrated in medium alone were cal-
culated with non-parametric Wilcoxon rank test.
CCL21 serum and SF concentrations
Forty-three sera (15 from controls) and 28 SFs were tested
for CCL21 by an enzyme-linked immunosorbent assay kit
from R&D System (Minneapolis, USA), in accordance with
the instructions of the manufacturer.
Serum levels of CCL21 were compared in three groups of
patients (12 patients with JIA with a polyarticular course,
16 patients with JIA with an oligoarticular course and 15
healthy controls) with the use of the non-parametric
Kruskal–Wallis ANOVA test. Correlations between all the
variables considered were evaluated with the non-paramet-
ric Spearman rank test. Differences between paired serum
and SF chemokine concentrations were evaluated by the
Wilcoxon rank test.
Immunohistochemical studies
Tissue specimens with sizes between 5 and 12 mm were
treated for single and double immunohistochemical stain-
ings with a standard technique as reported previously [22].
In brief, all specimens were fixed in 4% formalin for 24
hours, then dehydrated and embedded in paraffin. Sections
4 µm thick were layered on polylysine-coated slides. Slides
were deparaffinised in xylene, and rehydrated in a descend-
ing sequence of ethanol concentrations (100–70%).
Three different immunohistochemical techniques, namely
alkaline phosphatase–anti-alkaline phosphatase (APAAP)
for CCR7, avidin–biotin complex for CD21, and indirect
immunoperoxidase (CD3, CD4, CD45RO, CD20, CCR5,
CXCR3, CCL19 and CCL21), were performed after 30
min of warming in an oven in citrate buffer, pH 6, with sub-
sequent inhibition of endogenous peroxidase. For single
staining, tissue sections were incubated overnight at 4°C
with the anti-CCR7 murine mAb, clone 2H4 (Pharmingen).
Incubation of tissue sections with anti-CCL21 goat antise-
rum (R&D), anti-CCR5, clone 2D7 (Pharmingen), anti-
CXCR3, clone 1C6 (Pharmingen), anti-CD3 (Dako,
Glostrup, Denmark), anti-CD4, clone 4B12 (Neomarkers,
Fremont, CA, USA), anti-CD20, clone L26 (Dako) and anti-
CD45RO, clone UCHL1 (Menarini, Firenze, Italy) and anti-
CD31 clone JC70A (Dako) was performed overnight at
4°C.
Sections were subsequently reacted for 30 min at room
temperature (20–25°C) with (1) anti-mouse Ig antibody
conjugated to peroxidase-labelled dextran polymer (EnVi-Available online http://arthritis-research.com/content/7/2/R256
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sion; Dako) for CD3, CD45RO, CCR5 and CCR7 stain-
ings, (2) anti-goat secondary biotinylated antibody,
followed by high-sensitivity streptavidin–horseradish perox-
idase conjugate for CCL21 determination (Cell and Tissue
Staining kit; R&D), and (3) APAAP-conjugated rabbit anti-
mouse Ig (1:25 dilution; Dako) antibody for CCR7 determi-
nation. The chromogenic diaminobenzidine substrate
(Dako) was applied for 10 min. All washings were per-
formed by incubating the sections in PBS. For CCR7
determination the alkaline phosphatase reaction was per-
formed with a medium containing Tris-HCl buffer pH 8.2,
naphthol AS-TR salt (Sigma) and levamisole (Sigma), for
20 min at 98°C. Slides were counterstained with Mayer's
haematoxylin. For double CCR7/CCL21 staining, the sec-
tions were subjected to peroxidase reaction with goat
CCL21 and were washed three times in Tris-buffered
saline. Subsequently, the APAAP technique (see above)
was applied with the mouse CCR7 Ab (at room tempera-
ture, for 3 hours). The secondary reagents were applied for
30 min each. For CCR7 and CCL21, a reactive lymph node
from a 10-year-old boy was considered as positive control.
Reactions in the absence of primary antibody and with irrel-
evant antibodies of the same isotypes (anti-cytomegalovi-
rus, clones DDG9 and CCH2; Dako) were performed as
negative controls.
Slides were evaluated on two different occasions by two
blinded observers (MG and AG) and an expert pathologist
(CG). Each specimen was evaluated for the pattern of lym-
phocyte infiltration in three different categories: (1) aggre-
gates of T cells (CD4) and B cells (CD20) with germinal
centre (GC)-like reaction (presence of CD21-positive
cells), (2) aggregates of T and B cells without GC-like reac-
tion, and (3) diffuse lymphocytic infiltrate without lymphoid
organisation [20]. For each sample a semiquantitative
score for the overall degree of T lymphocyte infiltration
(CD3) was used (range 0–3). For the assessment of chem-
okine receptor expression each sample was subjected to
microscopical analysis of: (1) the lining layer and sublining
zone of the superficial subintima [23]; (2) perivascular infil-
trates of the sublining layer without lymphoid organisation;
(3) aggregates of T and B cells. Because CCR7, CXCR3
and CCR5 can be expressed by several cell types (lym-
phocytes, dendritic cells, B cells and plasma cells) [18,24],
only areas characterised by a clear lymphocyte infiltration
(as defined by anti-CD3 and anti-CD4 positivity) were
taken into consideration. The following semiquantitative
global score was based on a visual inspection of four differ-
ent high-power fields (40×) at each level: absent (-, no pos-
itive cells per high-power field), weakly positive (+, 1–10
positive cells per high-power field), moderately positive
(++, 10–20 positive cells per high-power field), and
strongly positive (+++, more than 20 positive cells per
high-power field). The assignment of each sample to one of
the above categories was based on the predominant pat-
tern observed. Minor differences between the observers
were resolved by mutual agreement. Intra observer and
interobserver variability was less than 5%.
Results
Phenotypic and functional characterisation of CCR7+ and 
CCR7- CD4+ memory T cells isolated from SF
Expression of CCR7 on CD4+ memory T cells from the PB
and SF of 10 patients with JIA was investigated by three-
colour immunofluorescence analysis and compared with
that detected on the same PB cell subset from eight age-
matched healthy controls.
The heterogeneity test between the three subgroups was
highly significant (Kruskal–Wallis ANOVA test, P  =
0.0001). At post hoc analysis, in the PB from patients with
JIA, the percentage of CCR7+ cells in the CD4+CD45RO+
subpopulation (median 65.5%, range 50–90%) was signif-
icantly lower than in PB from controls (median 76%, range
73–89%,  P  = 0.03, Mann–Whitney U-test). A further
decrease in CCR7+ cells was observed in memory CD4+
cells isolated from SF (median 41.2%, range 12–59%) in
comparison with paired PB.
Thus, even a variable proportion of SF memory CD4+ T
cells are positive for CCR7; this subpopulation is clearly
enriched in CCR7- cells in comparison with paired PB.
Next we investigated the expression of CCR5, CXCR3 and
IFN-γ in SF CD4+CD45RO+CCR7+ and CCR7- cells from
10 consecutive patients and compared it with that
detected in paired PB from 5 of these patients and in the
PB of 5 healthy controls. To this end, purified CD45RO+
cells were stained with anti-CD4, anti-CCR7 and respec-
tively, anti-CCR5, CXCR3 or IFN-γ mAbs in three-colour
immunofluorescence.
In SF, CCR5+ cells were found to be enriched in the
CD4+CD45RO+CCR7- lymphocyte subset (median 85%,
range 74–99%) as compared to the
CD4+CD45RO+CCR7+ cell fraction (median 65%, range
46–84%, P = 0.005; Wilcoxon test; not shown). These
data were in line with our previous observation of a higher
expression of CCR7 in 'early' CD27+ memory T cells and a
prevalent CCR7-CCR5+ phenotype in 'effector' CD27- T
cells in SF from patients with JIA [25]. The median
percentage of CD4+, CD45RO+, IFN-γ positive cells was
27% (range 21–46%) for CCR7+ cells and 40% (range
24–69%) for CCR7- cells (P  = 0.005) (Fig. 1a,c), as
assessed by intracellular staining. Accordingly, the mean
fluorescence intensity for IFN-γ was lower for CCR7+ cells
(median 136, range 84–184) than for paired CCR7- CD4+
memory T cells (median 190, range 127–307, P = 0.005).Arthritis Research & Therapy    Vol 7 No 2    Gattorno et al.
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CXCR3 was highly expressed on both CCR7+ and CCR7-
subsets of SF memory CD4+  T cells. However, in all
patients with JIA, SF CCR7+ memory CD4+ T cells showed
a higher expression of CXCR3 (median 86%, range 74–
93%) than the CCR7- counterpart (median 76%, range
62–85, P = 0.005) (Fig. 1b,d). In comparison with SF, PB
of patients with JIA showed a lower expression of CXCR3
in both CCR7+  (median 38.5%, range 24–55%) and
CCR7- (median 27%, range 17–40%) CD4+ memory T
cells. A similar expression was also found in circulating
CCR7+ (median 40%, range 32–55%) and CCR7- (median
17%, range 13–45%) CD4+ memory T cells from age-
matched healthy controls.
Taken together, these results show that the
CD4+CD45RO+CCR7-  subpopulation is enriched in
'effector' CCR5 and IFN-γ expressing cells, whereas the
CD4+CD45RO+CCR7+  subpopulation shows a lower
expression of CCR5 and IFN-γ and a higher degree of
coexpression with CXCR3.
Different localisation of CCR7, CXCR3 and CCR5 positive 
cells in synovial tissue
We next addressed the following questions: (1) is CCR7
expressed in synovial tissue, (2) how does its expression
correlate with the pattern of lymphocytic infiltration, and (3)
how is CCR7 expression related to that of CXCR3 and
CCR5, two Th1-associated chemokine receptors? To this
end, synovial tissues obtained a t  s y n o v i e c t o m y  f r o m  s i x
patients with JIA were analysed for the expression of
CCR7, CXCR3 and CCR5 in areas characterised by a
clear lymphocyte infiltration (Table 3).
Figure 1
Expression of CXCR3 and interferon (IFN)-γ by (SF) CCR7+ and CCR7- memory CD4+ cells from synovial fluid Expression of CXCR3 and interferon (IFN)-γ by (SF) CCR7+ and CCR7- memory CD4+ cells from synovial fluid. IFN-γ expression was investigated by 
three-colour staining of freshly isolated SF CD45RO+ cells with CD4–fluorescein isothiocyanate (FITC), anti-CCR7–phycoerythrin (PE) and anti-
CCR5–CyChrome monoclonal antibodies (mAbs) or CD4–TC (where TC stands for Tri-color), anti-CCR7–PE and anti-IFN-γ mAbs, respectively; 
CXCR3 expression was investigated by triple staining with CD4–TC, anti-CCR7–PE and anti-CXCR3–FITC, as described in the Methods section. 
Subsequently, cytofluorimetric analysis was performed by gating on the CD4+CCR7+ and CD4+CCR7- lymphocyte subsets. Data are expressed as 
percentages of positive cells or/and mean fluorescence intensity. (a, b) Expression of IFN-γ (a) and CXCR3 (b) by SF CCR7+ and CCR7- memory 
CD4+ cells from 10 patients with juvenile idiopathic arthritis (JIA). Boxes contain values falling between the 25th and 75th centiles; whiskers show 
lines that extend from the boxes represent the highest and lowest values for each subgroup. Differences between paired SF mononuclear cells were 
evaluated by the Wilcoxon rank test. (c, d) Dot plots show the cytofluorimetric analysis IFN-γ (c) and CXCR3 (d) expression by the gated 









































Different patterns in the synovial inflammatory infiltrate were
observed in the individual patients (Table 3). One patient
(no. 6) showed T and B cell aggregates with the presence
of a GC reaction, as demonstrated by the presence of
CD21+ follicular dendritic cells [20]. In three patients (nos
3, 4 and 5) clusters of T and B cell aggregates in the
absence of follicular dendritic cells were observed [20].
Two patients (nos 1 and 2) displayed diffuse lymphocytic
infiltrates as perivascular aggregates in the sublining layer
or scattered throughout the synovium up to the lining layer
[20].
CCR7-positive cells were detected both in cases showing
a diffuse lymphocytic infiltrate (Fig. 2a,b) and in those dis-
playing a more organised lymphoid structure (Fig. 2c–e). In
the former, CCR7 expression was detected mostly in the
perivascular lymphocytic infiltrates of the sublining layer
(Fig. 2b,o) and, only occasionally, in scattered cells in the
sublining zone of the superficial subintima (see also Fig. 4c
below). In the latter, CCR7-positive cells were localised
inside and around lymphoid aggregates (Fig. 2e).
Because naive CD45RA+ T cells with a CCR7+ phenotype
had also previously been found to infiltrate the synovial tis-
sue from patients with RA [19], serial sections were stained
with CCR7 and CD45RO antibodies. A clear positivity for
CCR7 was detected in lymphocytic infiltrates staining
heavily for CD45RO (not shown).
CXCR3 was abundantly expressed in all lymphocyte-infil-
trated areas examined (Table 3). In fact, CXCR3-positive
cells were detected in lymphoid aggregates (Fig. 2f) and in
perivascular infiltrates of sublining layer (Table 3). In many
areas, CXCR3 and CCR7 displayed a similar pattern of tis-
sue distribution, especially at the level of lymphocyte aggre-
gates (Fig. 2e,f).
Conversely, CCR5-positive cells were detected mainly in
the lining layer and in the sublining zone of the superficial
subintima and, to a smaller extent, in the perivascular infil-
trates of the sublining layer (Fig. 2p) and in the T and B cell
aggregates (Fig. 2n) (Table 3).
Altogether, even if a certain degree of co-localisation of the
two chemokine receptors was found (Table 3), CCR5
positive cells showed a substantially different tissue distri-
bution from that of CCR7, either in T and B cell aggregates
(Fig. 2e,g,l,n) or in diffuse lymphocytic infiltrates (Fig. 2o,p).
Conversely, a variable degree of co-localisation was found
for CCR5 and CXCR3 at the level of the sublining and lin-
ing layer (Table 3).
Chemotaxis of SF CD4+ memory T cells to inflammatory 
and homeostatic chemokines
In further experiments, chemotaxis of freshly isolated SF
memory T cells in response to CCR7, CCR5 and CXCR3
ligands was investigated, and migrated CD4+CD45RO+ T
cells were detected by flow cytometry.
Chemotactic assays were performed with SF CD45RO+
cells isolated from eight patients with JIA (five with pOJIA,
three with eOJIA) and tested in the presence or absence of
two inflammatory chemokines that bind to CCR5 (CCL3)
and CXCR3 (CXCL11), respectively, and of homeostatic
chemokines binding to CCR7 (CCL21 and CCL19).
CD4+CD45RO+  T cells migrated significantly to both
CCL3 and CXCL11 (P = 0.02 for both chemokines). Sim-
ilar responses were observed when CCL19 was tested (P
= 0.02). Chemotaxis of CD4+ memory T cells to CCL21
approached but did not reach statistical significance (P =
0.1) (Fig. 3). The latter finding might be related to the lim-
ited number of the samples tested.
Table 3
Distribution of chemokine receptors of synovial tissues from patients with juvenile idiopathic arthritis
Patient no. Age (year) Form Pattern CD3 CCR7 CXCR3 CCR5
Lining Sublining Aggregates Lining Sublining Aggregates Lining Sublining Aggregates
1 14 Oligo per. Diffuse +++ + +++ NP +++ +++ NP +++ ++ NP
2 19 Poly RF- Diffuse + - ++ NP + +++ NP + - NP
3 10 Oligo per. T-B ++ - + ++ + ++ ++ ++ + -
4 12 Oligo ext. T-B +++ ++ +++ +++ ++ +++ +++ ++ + ++
5 7 Poly RF- T-B ++ - - + ++ +++ +++ +++ + +
6 15 Poly RF- GC +++ - + ++ +++ +++ +++ +++ + -
Oligo per., persistent oligoarticular; oligo ext., extended oligoarticular; Poly RF-, polyarticular rheumatoid factor-negative; NP, not present; T-B, 
aggregates of T and B cells; GC, T and B cell aggregates with germinal centre (GC)-like reaction. Scoring: -, absence of positive cells in high-power 
field; +, 1–10 positive cells per high-power field; ++, 10–20 positive cells per high-power field; +++, more than 20 positive cells per high-power 
field (see also the Methods section). Lining, lining layer and superficial subintima; sublining, perivascular infiltrates in sublining layer; aggregates, T 
and B cell aggregates with or without GC-like reaction. All evaluations were performed in areas characterised by a clear lymphocyte (anti-CD3 and 
anti-CD4 positive cells) infiltration (see also the Methods section and Fig. 3).Arthritis Research & Therapy    Vol 7 No 2    Gattorno et al.
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In the patients studied, the variability of chemotaxis of SF
CD4+  memory T cells did not show any significant
correlation with disease form, degree of disease activity
and treatment at the moment of sampling.
Expression of CCL21 in SF and synovial tissue
To gain further insight into the relevance of the interactions
between CCR7 and its ligand CCL21 in vivo, sera and SF
CCL21 concentrations were tested in 28 consecutive
patients with JIA and in 15 healthy controls.
The heterogeneity test between the three subgroups was
highly significant (Kruskal–Wallis ANOVA test, P  =
0.0045). Concentrations of CCL21 were significantly
higher in SF (median 1769.5 pg/ml, range 110–25,556
pg/l) than in paired sera from patients with JIA (median 268
pg/ml, range 57.6–5146.9 pg/ml, P < 0.0001; Wilcoxon
test; Fig. 4a).
A strong correlation was found between paired serum and
SF CCL21 concentrations (r = 0.91, P = 0.001; Spear-
man's test).
No significant difference was observed in CCL21 serum
concentrations between patients with JIA with oligoarticu-
lar course (median 229.2 pg/ml, range 67–3948 pg/ml),
patients with JIA with polyarticular course (median 378 pg/
ml, range 65–5146 pg/ml) and age-matched healthy con-
trols (median 282.2 pg/ml, range 76–2349 pg/ml, P = 0.3;
Kruskal–Wallis ANOVA test). Similarly, no significant differ-
Figure 2
Expression of CD4, CD20, CD45RO, CCR7, CCR5 and CXCR3 in synovial tissue obtained from patients with juvenile idiopathic arthritis (JIA) after  synoviectomy Expression of CD4, CD20, CD45RO, CCR7, CCR5 and CXCR3 in synovial tissue obtained from patients with juvenile idiopathic arthritis (JIA) after 
synoviectomy. (a, b) Presence of CCR7+ cells (red) in the sublining layer of a synovial tissue characterised by a diffuse lymphocytic infiltrate (scat-
tered CD4+ cells, brown) from a 14-year-old girl with antinuclear antibody-positive (ANA+) oligoarticular JIA (no. 1, Table 3) (Magnification × 20). (c–
n) Serial stainings with CD20, CD4, CCR7, CXCR3 and CCR5 monoclonal antibody in synovial tissue from a 12-year-old girl with ANA+ oligoartic-
ular JIA (no. 4, Table 3). The distribution of cells positive for CCR7, CCR5 and CXCR3 is shown in two different areas containing T and B cell aggre-
gates (magnification × 10). (o, p) Different expression of CCR7 (red) and CCR5 (brown) in synovial membrane infiltrate (patient no. 1, Table 3) 
(magnification × 4.5). CCR7+ cells are observed exclusively in the perivascular lymphocytic infiltrate of the deep sublining layer (open rectangle). 
Conversely, CCR5-positive cells are prevalently observed at the level of the lining layer and superficial subintima (*) and in the perivascular infiltrates 
of the sublining layer (**).Available online http://arthritis-research.com/content/7/2/R256
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ence was found in SF CCL21 concentrations between
patients with JIA with an oligoarticular course and patients
with a polyarticular course (P = 0.52; Mann–Whitney U-
test).
Finally, no significant correlation was found between
CCL21 serum concentrations and several clinical and lab-
oratory parameters of disease activity in patients with JIA
(see the Methods section; not shown).
The expression of CCL21 was also analysed in synovial tis-
sues by immunohistochemistry. CCL21 was detected in all
specimens. In the samples characterised by lymphoid
organisation, CCL21 staining was observed in the perivas-
cular lymphocytic aggregates and in the vascular endothe-
lium within follicular structures, a pattern reminiscent of that
observed on staining for CCR7 [19]. A similar pattern was
detected in tissues showing a diffuse lymphocytic infiltra-
tion (Fig. 4b). Moreover, a clear-cut expression of CCL21
was also observed in flat wall vessels of the superficial
subintima of the sublining layer (Fig. 4c,d) [23].
Discussion
In this study we have investigated the role of CCR7 in the
recruitment of CD4+ memory T cells into the inflamed joints
of patients with JIA, and attempted the functional and ana-
tomical dissection of these cells according to their expres-
sion of CCR7, CXCR3, CCR5 and IFN-γ. We detected two
populations of SF CD4+  memory T cells: the
CD4+CD45RO+CCR7-  subset, which was enriched in
'effector' CCR5 and IFN-γ positive cells, and the
CD4+CD45RO+CCR7+ subset, which was less well repre-
sented and showed higher CXCR3 coexpression. SF
CD4+ memory T cells displayed chemotactic activity to
both inflammatory and homeostatic chemokines represent-
ing the physiological ligands of these receptors.
Of the three chemokine receptors studied, CXCR3 proved
to be the most widely expressed in synovial tissue, with a
clear distribution both in lymphoid aggregates and in
perivascular infiltrates of sublining layer and in the lining
layer.
Conversely, CCR7-positive and CCR5-positive cells in the
synovial tissue displayed a different distribution, showing
an even higher differentiation in their expression in respect
to SF. In fact, CCR7+ cells were detected in synovial tis-
sues irrespective of the pattern of lymphoid organisation
and were localised mainly in lymphoid aggregates and in
perivascular infiltrates of the sublining layer. Notably,
CCL21, the CCR7 ligand, was found in the SF as well as
in perivascular lymphocytic aggregates and in the vascular
endothelium of follicular structures.
In contrast, CCR5+ cells were detected mainly in the lining
layer and in the sublining zone of the superficial subintima
and, to a smaller extent, in the perivascular infiltrates of sub-
lining layer and in the T and B cell aggregates.
These findings in synovial tissue are in line with the results
of the phenotypic characterisation of SF CCR7+  and
CCR7- memory CD4+ T cells performed in the present
study and with previous observations showing a variable
degree of coexpression of CXCR3 and CCR5 on T cells
isolated from inflamed tissues [14,26,27].
To our knowledge, this is the first demonstration of a differ-
ent anatomical localisation of cells positive for CCR7,
CCR5 and CXCR3 infiltrating the inflamed synovium; this
finding may have functional implications for the intra-tissue
migration of T cells.
During the past decade several studies have focused on
the capacity of memory T cells to differentiate in the context
of inflamed tissues. Many of these studies used a member
of the tumour necrosis factor receptor family, CD27, to dis-
tinguish recently activated CD27+ from 'effector' CD27-
memory CD4+ T cells [28]. Notably, a clear enrichment of
the latter subpopulation has been found in SF of patients
with RA and JIA [29,30]. In a recent study we showed that
CD27+ memory T cells in SF of patients with JIA expressed
CCR7 more highly than CCR5, whereas CD27- T cells dis-
played a prevalent CCR7- CCR5+ phenotype [25]. Notably,
the immunohistochemical characterisation of rheumatoid
synovial tissue in adult RA has shown a prevalent localisa-
tion of CD4+CD27+ T cells in the perivascular lymphocytic
aggregates, with a relative increase in CD27- T cells in dif-
fuse lymphocytic infiltrates [31].
Thus, it is conceivable that the functional and phenotypic
characterisation of CCR7+ and CCR7- memory CD4+ T
cells and the different tissue distribution between CCR7
Figure 3
Chemotactic activity of CD4 memory T cells from the synovial fluid of  eight patients with juvenile idiopathic arthritis to inflammatory (CXCL11  and CCL3) and homeostatic (CCL19, CCL21) chemokines Chemotactic activity of CD4 memory T cells from the synovial fluid of 
eight patients with juvenile idiopathic arthritis to inflammatory (CXCL11 
and CCL3) and homeostatic (CCL19, CCL21) chemokines. Results 
are expressed as the percentage of migrated cells in the total cell input 
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and CCR5 found in the present study might reflect the
same behaviour already observed for CD27+ and CD27-
memory T cells, yielding more insight into the migratory
properties of memory T cells into and within the synovial
tissue.
The partial overlap of CCL21 and CCR7 expression in the
inflamed synovium might suggest that the CCR7/CCL21
system, probably in synergy with CXCR3 and its ligands, is
involved in the recruitment of memory T cells, as already
shown for naive T cells [19]. However, the possibility can-
not be ruled out that CCR7 expression in CD4+ memory T
Figure 4
Expression of CCL21 in synovial fluid and tissue Expression of CCL21 in synovial fluid and tissue. (a) CCL21 concentrations in sera from 15 age-matched healthy controls, paired sera (Sera) and 
synovial fluids (SF) from 28 patients with juvenile idiopathic arthritis (JIA). Lines represent median values. Boxes contain values falling between the 
25th and 75th centiles; whiskers show lines that extend from the boxes represent the highest and lowest values for each subgroup. The heterogene-
ity test among the three subgroups was highly significant (Kruskal–Wallis analysis of variance test, P = 0.0045). At post hoc analysis, differences 
between paired sera and SF were evaluated by the Wilcoxon rank test. Difference between JIA sera and healthy controls were evaluated by the 
Mann–Whitney U-test. (b) Expression of CCL21 in perivascular aggregates and vascular endothelium in synovial tissue with diffuse lymphocytic infil-
tration from 10-year-old girl with persistent oligoarticular JIA. (c, d) Double staining with anti-CCR7 (red) and anti-CCL21 (brown) monoclonal anti-
bodies at different magnifications (×10 and ×40, respectively) shows CCL21 expression by endothelial cells of vessels located in the sublining zone 






















cells isolated from SF was upregulated after the reactiva-
tion of these cells at the site of inflammation [32].
CCL21, together with other homeostatic chemokines such
as CXCL13, has been shown to have a fundamental func-
tion in the development of secondary lymphoid organs by
interacting with CCR7 [4,33]. Mice whose CCR7 or
CCL21 genes have been knocked out exhibit marked defi-
ciencies in the structural and cellular composition of lymph
nodes [34].
A sequence of events similar to that taking place in lymph
node organogenesis is supposed to be involved in the
development of organised lymphoid structures in inflamed
tissues, such as the rheumatoid synovium [18-20]. Indeed,
up to 20% of synovial tissue biopsies from patients with RA
show the typical features of the GC reaction. Other
patients show aggregates of T and B cells in the absence
of an evident follicular organisation [20], whereas in more
than 50% of synovial tissue samples from RA [20] and a
considerable proportion of patients with JIA (M Gattorno,
unpublished data), diffuse T and B lymphocytic infiltrates in
the absence of aggregates or follicular structures are
observed. Interestingly, in the individual patients with RA,
the pattern of lymphocytic infiltration was found to persist
unaltered over time, and showed similar features in all biop-
sies taken from different joints at the same type [20].
In our study, both CCR7 and its ligand CCL21 were found
to be abundantly expressed in synovial biopsies, irrespec-
tive of the pattern of lymphoid infiltration. These observa-
tions support the hypothesis that CCR7 and its ligands
have a direct function in the recruitment of memory T cells
to the inflamed synovium, one that is independent of their
ability to organise in lymphoid structures.
In this respect, the recent demonstration of different regu-
lation of CCL21 in lymphoid and non-lymphoid tissues is
noteworthy. Lymphotoxin-α directs the formation of lymph
nodes and Peyer's patches through the induction of adhe-
sion molecules and the production of chemokines, includ-
ing CCL21, by the mesenchymal organiser cells during the
early developmental steps [4,35]. Lymphotoxin-α-deficient
mice show a marked impairment of lymphoid organisation
in secondary lymphoid organs, but normal recruitment of
naive and memory T cells to peripheral inflamed tissue
through the CCR7/CCL21 system [36]. CCL21 and
CCR7 might therefore either regulate lymphoid neogenesis
by a lymphotoxin-dependent mechanism or recruit T cells to
the inflamed tissues by a lymphotoxin-independent
mechanism.
Taken together, our findings suggest that CCR7+ memory
T cells can be directly recruited, with the possible contribu-
tion of other chemokines such as CXCR3 ligands, to the
synovium, where they undergo further differentiation lead-
ing to the downregulation of CCR7 from the cell surface
and the concomitant upregulation of CCR5. This differenti-
ation might be driven either by antigen-dependent or anti-
gen-independent mechanisms. In fact, cytokines produced
in the synovial microenvironment (namely interleukin-7 and
interleukin-15) might allow the proliferation, expansion and
differentiation of CCR7+ memory T cells into effector cells,
marked by the downregulation of CCR7, the upregulation
of CCR5 and the production of IFN-γ [37]. In this model,
CCR5 could represent the major chemokine receptor used
for CD4+ memory T cell locomotion within the inflamed tis-
sue, according to a step-by-step navigation model through
different chemoattractant gradients [38]. In contrast, the
enrichment of CCR7- CCR5+ cells infiltrating the lining and
sublining layer could be also related to the presence of
other relevant effector cells, such as the granzyme B+ cyto-
toxic cells [39].
Conclusion
The present study delineates a coordinated pattern of
expression of homeostatic and inflammatory chemokines in
the inflamed synovium, with potential implications for the
mechanisms regulating the intra-tissue migration and local
differentiation of inflammatory cells.
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